Today we go deep into Numinus Wellness.  Numinus (also known as Numi) is a Canadian Psychedelic startup that many people think is undervalued.  This episode looks into this claim and tries to answer questions like:

• Who is Numi's team?
• Is Numi's natural psilocybin superior to synthetic psilocybin? 
• Why is Numi's market cap so low compared to the leading psychedelic companies?
• What's the deal with Numi's MAPS collaberation?
• Can Numi (or any other company) make money running psychedelic clinics? 

You can watch this episode on YouTube https://youtu.be/jg2H0sMHZXg

See Brom's other links https://linktr.ee/therealbrom

Disclaimer:  This video is not financial advice.  Do you own research before buying or selling any stock, and talk to a financial advisor whos incentives are aligned with your own.  Brom owns shares of Numi as well as other psychedelic companies.